title: Blood pressure is associated with higher brain amyloid burden and lower glucose metabolism in healthy late middle-age persons.
abstract: Epidemiological studies suggest that elevated blood pressure (BP) in midlife is associated with increased risk of Alzheimer's disease (AD) in late life. In this preliminary study, we investigated the extent to which BP measurements are related to positron emission tomography (PET) measurements of fibrillar amyloid-beta burden using Pittsburgh Compound-B (PiB) and fluorodeoxyglucose (FDG) PET measures of cerebral metabolic rate for glucose metabolism (CMRgl) in cognitively normal, late middle-aged to older adult apolipoprotein E (APOE) ε4 homozygotes, heterozygotes and noncarriers. PiB PET results revealed that systolic BP (SBP) and pulse pressure (PP) were each positively correlated with cerebral-to-cerebellar PiB distribution volume ratio (DVR) in frontal, temporal, and posterior-cingulate/precuneus regions, whereas no significant positive correlations were found between PiB distribution volume ratios and diastolic BP (DBP). FDG PET results revealed significant inverse correlations between each of the BP measures and lower glucose metabolism in frontal and temporal brain regions. These preliminary findings provide additional evidence that higher BP, likely a reflection of arterial stiffness, during late midlife may be associated with increased risk of presymptomatic AD.
authors.affiliation: Banner Alzheimer's Institute, Phoenix, AZ 85006, USA. jessica.langbaum@bannerhealth.com
authors.forename: Jessica B S
authors.initials: JB
authors.lastname: Langbaum
authors.forename: Kewei
authors.initials: K
authors.lastname: Chen
authors.forename: Lenore J
authors.initials: LJ
authors.lastname: Launer
authors.forename: Adam S
authors.initials: AS
authors.lastname: Fleisher
authors.forename: Wendy
authors.initials: W
authors.lastname: Lee
authors.forename: Xiaofen
authors.initials: X
authors.lastname: Liu
authors.forename: Hillary D
authors.initials: HD
authors.lastname: Protas
authors.forename: Stephanie A
authors.initials: SA
authors.lastname: Reeder
authors.forename: Daniel
authors.initials: D
authors.lastname: Bandy
authors.forename: Meixiang
authors.initials: M
authors.lastname: Yu
authors.forename: Richard J
authors.initials: RJ
authors.lastname: Caselli
authors.forename: Eric M
authors.initials: EM
authors.lastname: Reiman
mesh_terms: D000367:Age Factors; D000368:Aged; D016229:Amyloid beta-Peptides / Q000378:metabolism*; D000814:Aniline Compounds / Q000378:metabolism; D053327:Apolipoprotein E4 / Q000235:genetics; D001794:Blood Pressure / Q000235:genetics / Q000502:physiology*; D001921:Brain / Q000000981:diagnostic imaging / Q000378:metabolism*; D001931:Brain Mapping; D005260:Female; D019788:Fluorodeoxyglucose F18 / Q000378:metabolism; D005947:Glucose / Q000378:metabolism; D006801:Humans; D008297:Male; D008875:Middle Aged; D049268:Positron-Emission Tomography; D013844:Thiazoles / Q000378:metabolism
chemical_list: C475519:2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole; D016229:Amyloid beta-Peptides; D000814:Aniline Compounds; D053327:Apolipoprotein E4; D013844:Thiazoles; D019788:Fluorodeoxyglucose F18; D005947:Glucose